A Trial of the Efficacy and Safety of SEP-363856 in Acutely Psychotic Participants With Schizophrenia
for Schizophrenia
13 locations incl. Little Rock
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Sex: All·Age: 18 - 65
Code: NCT06894212·Phase 3·Recruiting·Listed Mar 2025